Free Trial
NASDAQ:BPTH

Bio-Path (BPTH) Stock Price, News & Analysis

Bio-Path logo
$0.15 +0.00 (+1.60%)
As of 08/1/2025 02:14 PM Eastern

About Bio-Path Stock (NASDAQ:BPTH)

Key Stats

Today's Range
$0.15
$0.15
50-Day Range
$0.15
$0.22
52-Week Range
$0.12
$3.39
Volume
11,517 shs
Average Volume
197,328 shs
Market Capitalization
$1.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bio-Path Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

BPTH MarketRank™: 

Bio-Path scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bio-Path.

  • Earnings Growth

    Earnings for Bio-Path are expected to grow in the coming year, from ($3.34) to ($1.55) per share.

  • Price to Book Value per Share Ratio

    Bio-Path has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bio-Path's valuation and earnings.
  • Percentage of Shares Shorted

    0.37% of the outstanding shares of Bio-Path have been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently increased by 453.57%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bio-Path does not currently pay a dividend.

  • Dividend Growth

    Bio-Path does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.37% of the outstanding shares of Bio-Path have been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently increased by 453.57%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bio-Path this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Bio-Path to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bio-Path insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.72% of the stock of Bio-Path is held by insiders.

  • Percentage Held by Institutions

    Only 5.74% of the stock of Bio-Path is held by institutions.

  • Read more about Bio-Path's insider trading history.
Receive BPTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter.

BPTH Stock News Headlines

Bio-Path Holdings, Inc. (BPTH) - Yahoo Finance
The stealth altcoin the financial world is underestimating
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.
See More Headlines

BPTH Stock Analysis - Frequently Asked Questions

Bio-Path's stock was trading at $1.16 on January 1st, 2025. Since then, BPTH shares have decreased by 86.9% and is now trading at $0.1524.

Bio-Path Holdings, Inc. (NASDAQ:BPTH) announced its earnings results on Thursday, August, 15th. The company reported ($1.16) earnings per share for the quarter, beating the consensus estimate of ($1.54) by $0.38.
Read the conference call transcript
.

Bio-Path's stock reverse split on the morning of Friday, February 23rd 2024.The 1-20 reverse split was announced on Friday, February 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of BPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bio-Path investors own include NVIDIA (NVDA), Canopy Growth (CGC), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU), Anavex Life Sciences (AVXL) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
8/15/2024
Today
8/01/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BPTH
CIK
1133818
Fax
N/A
Employees
10
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-2,842.40%
Return on Assets
-337.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
0.86

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
8,308,000
Free Float
5,726,000
Market Cap
$1.27 million
Optionable
Optionable
Beta
-0.03

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BPTH) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners